MedicarePartD.guide

A non-government resource built from CMS public data

Acid reducers (PPIs and Voquezna) on every 2026 Virgin Islands Part D plan

Pick a drug class, or type the drugs you want to check, and see which of the 1 stand-alone Part D plans in Virgin Islands cover each one, on what tier, and with what restrictions.

A class overrides typed names. Separate names with commas; brand or generic both work.

  • Covered
  • Covered, needs prior authorization (PA) or step therapy (ST)
  • Not on the formulary
  • QL 60/30d = quantity limit, 60 units per 30 days
Acid reducers (PPIs and Voquezna) by 2026 Virgin Islands Part D plan
DrugAARP Medicare Rx Preferred from UHC$114.80/moS5820-038
omeprazolegeneric PrilosecTier 125%
pantoprazolegeneric ProtonixTier 125%QL 90/30d
esomeprazolegeneric NexiumTier 325%QL 90/30d
lansoprazolegeneric PrevacidTier 225%QL 60/30d
rabeprazolegeneric AciphexTier 325%
dexlansoprazolegeneric DexilantTier 425%QL 30/30d
famotidinegeneric Pepcid (H2 blocker)Tier 125%
VoqueznavonoprazanTier 4PA25%

Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.